Cetuximab’s has found effective in EGFR over expressing cancer cells, which is conjugated TH (THC3) with intercalated doxorubicin (DOX) medication, or THDC3, demonstrated preferential death of MDA-MB-468 cancer cells (122). The gene discussed is EGFR; the disease is cancer.